Windtree Therapeutics - Warrants (25/03/2026) (WINT+) Q1 2019 Earnings

16AprExpected
Q2 2018
Q3 2018
Q4 2018
Q1 2019
-3.12
-1.81
-0.5
0.81

Details

Expected EPS
N/A
Actual EPS
-0.6
Surprise EPS
-0.6
Surprise Percent
+∞%

Description

Windtree Therapeutics - Warrants (25/03/2026) (WINT+) has reported earnings of -0.6 per share for Q1 2019.

0 Comments

Share your thoughts